no more compounding glp 1 drugs Managing Compounded GLP-1 Medications: A Pharmacist's Guide for Employers – Sequoia GLP-1 Safety Check - National

& Ferrannini, E

If NAION is associated with the use of GLP-1 RA medications, given the rapidly increasing use of these medications, it seems likely that cases of NAION will increase

10.2337/diabetes.52.1.124

No benefit in terms of the risk of HF hospitalization was observed with oral semaglutide, as well as with efpeglenatide (43, 44)

Absolute Contraindications Do not use GLP-1 and dual GIP/GLP-1 medications if you have any of the following: A personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) A history of pancreatitis or symptomatic gastroparesis Severe gastrointestinal disease Pregnant or planning pregnancy Final Thoughts GLP1 and dual GIP/GLP1 receptor are now widely used to help manage type 2 diabetes and obesity

When neither is ideal and alternatives are better Some patients are better served by single GLP-1 agonists like semaglutide